Schott Pharma
1SXP | F
Overview
Corporate Details
- ISIN(s):
- DE000A3ENQ51
- LEI:
- 529900TU48UE99NHEY88
- Country:
- Germany
- Address:
- Hattenbergstraße 10, 55122 Mainz
- Website:
- https://www.schott-pharma.com/en
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Schott Pharma is a leading pharmaceutical company dedicated to improving the quality of life through the development and production of innovative healthcare solutions. With a rich history dating back over a century, Schott Pharma has established itself as a trusted name in the industry, known for its commitment to excellence and unwavering focus on patient care. At Schott Pharma, our mission is to provide safe, effective, and accessible medications that address the evolving needs of patients worldwide. We believe in the power of research and collaboration, working closely with healthcare professionals, scientists, and regulatory authorities to develop breakthrough therapies that make a difference. Our state-of-the-art facilities are equipped with advanced technologies and adhere to the highest quality standards, ensuring that every product we manufacture meets stringent regulatory requirements. From pharmaceutical packaging solutions to drug delivery systems.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-11 08:50 |
Board/Management Change
SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appo…
|
English | 12.3 KB | |
2025-06-04 15:30 |
Regulatory News Service
SCHOTT Pharma invests in sterile cartridge production in Hungary
|
English | 8.9 KB | |
2025-05-16 00:00 |
Regulatory News Service
Half-yearly financial report 2024/2025
|
English | 885.8 KB | |
2025-05-15 07:00 |
Earnings Release
SCHOTT Pharma delivers strong second quarter of fiscal year 2025
|
English | 33.6 KB | |
2025-05-15 00:00 |
Regulatory News Service
Presentation H1 2025
|
English | 672.0 KB | |
2025-05-06 07:00 |
Regulatory News Service
SCHOTT Pharma and Serum Institute of India welcome new partner to Joint Venture…
|
English | 15.0 KB | |
2025-04-11 18:15 |
Regulatory News Service
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed …
|
English | 5.4 KB | |
2025-04-10 15:58 |
Regulatory News Service
Next expansion milestone achieved: SCHOTT Pharma opens production facility in S…
|
English | 9.6 KB | |
2025-04-02 16:00 |
Regulatory News Service
|
English | 4.8 KB | |
2025-02-14 07:00 |
Earnings Release
SCHOTT Pharma records good start into fiscal year and confirms full year outlook
|
English | 23.5 KB | |
2025-02-13 07:00 |
Earnings Release
SCHOTT Pharma records good start into fiscal year and confirms full year outlook
|
English | 23.5 KB | |
2025-02-13 00:00 |
Regulatory News Service
Presentation Q1 2025
|
English | 893.1 KB | |
2025-02-13 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2024/2025
|
English | 693.2 KB | |
2025-02-04 18:22 |
Regulatory News Service
SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all …
|
English | 14.5 KB | |
2025-01-14 13:55 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.0 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Camurus | Sweden | CAMX | |
![]() |
Cannabotech Ltd. | Israel | CNTC | |
Canzon Israel Ltd. | Israel | CNZN | ||
![]() |
CATALYST MEDIA GROUP PLC | United Kingdom | CMX | |
![]() |
Celon Pharma S.A. | Poland | CLN | |
|
Chemical Works of Gedeon Richter Plc | Hungary | RICHT | |
![]() |
COSMO Pharmaceuticals N.V. | Netherlands (Kingdom of the) | COPN | |
![]() |
DanCann Pharma A/S | Denmark | DANCAN | |
![]() |
DARWIN AG | Germany | 7V0 | |
|
Dechra Pharmaceuticals PLC | United Kingdom | DPH |